<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04829578</url>
  </required_header>
  <id_info>
    <org_study_id>20-AOIP-01</org_study_id>
    <secondary_id>2020-A03263-36</secondary_id>
    <nct_id>NCT04829578</nct_id>
  </id_info>
  <brief_title>Hypnosis for Chronic Idiopathic Pruritus</brief_title>
  <official_title>A Prospective Study of Hypnosis for Chronic Idiopathic Pruritus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nice</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nice</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chronic idiopathic pruritus (CIP) is a frequent and disabling condition, for which there is&#xD;
      no specific treatment. It was shown previously that hypnosis can relieve painful sensations.&#xD;
      Pain and pruritus share many similarities regarding sensory receptors and pathways,&#xD;
      suggesting that hypnosis might help relief CIP.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Chronic idiopathic pruritus (CIP) is a frequent and disabling condition, with significative&#xD;
      impact on quality of life. At present, there is no specific treatment for CIP. Topical&#xD;
      steroids are frequently used, with partial efficacy, and adverse effects. Hypnosis is a&#xD;
      specific state of conscience. It differs from waking state, sleeping state, relaxation, or&#xD;
      meditation. In this state, the person is highly responsive to suggestion. In medicine,&#xD;
      hypnosis can be used to engage the internal resources of the person against unpleasant&#xD;
      feelings. It was shown previously that hypnosis can relieve painful sensations. Pain and&#xD;
      pruritus share many similarities regarding sensory receptors and pathways, suggesting that&#xD;
      hypnosis might help relief CIP.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 1, 2021</start_date>
  <completion_date type="Anticipated">October 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change From Baseline in Pruritus Numeric Rating Scale</measure>
    <time_frame>Day 84</time_frame>
    <description>Assessment of the intensity of pruritis in Pruritus Numeric Rating Scal; the minimum and maximum values 0 to 10</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Pruritus Verbal Rating Scale</measure>
    <time_frame>Day 84</time_frame>
    <description>Assessment of Pruritus by pruritus Verbal Rating Scale; the minimum and maximum values 0 to 4</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Sleeping Scale</measure>
    <time_frame>Day 84</time_frame>
    <description>assessment in sleeping scale ; the minimum and maximum values 0 to 10</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in DLQI scale</measure>
    <time_frame>Day 84</time_frame>
    <description>assessment in DLQI scale; result between 0 to 30</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in HAD scale</measure>
    <time_frame>Day 84</time_frame>
    <description>assessment in HAD scale; result between 0 to 42</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in usage of topical steroids</measure>
    <time_frame>Day 84</time_frame>
    <description>assessment in usage of topical steroids</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of tolerance of hypnosis</measure>
    <time_frame>Day 84</time_frame>
    <description>assessment of tolerance of hypnosis with report of adverse event</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Chronic Idiopathic Pruritus</condition>
  <arm_group>
    <arm_group_label>Hypnosis</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>hyspnosis treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Hypnosis</intervention_name>
    <description>Chronic idiopathic pruritus is treated by hypnosis</description>
    <arm_group_label>Hypnosis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or female of at least 18 years at screening&#xD;
&#xD;
          -  Diagnosis of chronic (at least 6 wks.) idiopathic pruritus&#xD;
&#xD;
          -  Pruritus Numeric Rating Scale &gt; = 4&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pruritus caused by a dermatological or a systemic conditions&#xD;
&#xD;
          -  Suicidal crisis, moderate, or severe&#xD;
&#xD;
          -  Psychosis (schizophrenia, persistent delusional disorder)&#xD;
&#xD;
          -  Bipolar disorder, not stabilized or decompensating&#xD;
&#xD;
          -  Personality disorder, decompensated&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>BAHADORAN PHILIPPE</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Universitaire de Nice</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>CAUSERET Marion</last_name>
    <phone>0492034702</phone>
    <email>causeret.m@chu-nice.fr</email>
  </overall_contact>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 26, 2021</study_first_submitted>
  <study_first_submitted_qc>March 31, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 2, 2021</study_first_posted>
  <last_update_submitted>March 31, 2021</last_update_submitted>
  <last_update_submitted_qc>March 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pruritus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

